Dissolved and financials
CVR: 28106351
Previous names: MEDICAL PROGNOSIS INSTITUTE ApS, MEDICAL PROGNOSIS INSTITUTE A/S, ONCOLOGY VENTURE A/S
DKK -81,000
Gross profit
Net result: DKK -83,000
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 16 October 2025
CVR · view overview
6 employees
CVR · 2021
Director role ended: Lars Lüthjohan
CVR · 16/10/2025
View the full event history
Allarity Therapeutics A/S was a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company has been dissolved on 16 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ONCOLOGY VENTURE A/S and MEDICAL PROGNOSIS INSTITUTE A/S. The company has 6 employees (2021). In 2024, the company reported a gross profit of DKK -81,000 and a net result of DKK -83,000 compared with DKK -406,000 the year before. Equity in the 2024 report amounted to DKK 0.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 0 | -83 t. | 78 t. | 0 | - | |
| 202301/01/2023 – 31/12/2023 | 0 | -406 t. | 416 t. | 83 t. | - | |
| 202201/01/2022 – 31/12/2022 | 0 | -14.6 mio. | 889 t. | 488 t. | 0 | |
| 202101/01/2021 – 31/12/2021 | - | 565.8 mio. | 32 mio. | 31.3 mio. | 7 | |
| 202001/01/2020 – 31/12/2020 | 0 | -47.7 mio. | 176.9 mio. | 140.6 mio. | - | |
| 201901/01/2019 – 31/12/2019 | 801 t. | -138.1 mio. | 181.2 mio. | 141.3 mio. | - | |
| 201801/01/2018 – 31/12/2018 | 2.1 mio. | -15.5 mio. | 251.5 mio. | 181.9 mio. | - | |
| 201701/01/2017 – 31/12/2017 | 5.1 mio. | -30.4 mio. | 13 mio. | 2.4 mio. | - | |
| 201601/01/2016 – 31/12/2016 | 5 mio. | -8.7 mio. | 53.6 mio. | 50.2 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 5.8 mio. | -8.4 mio. | 17.7 mio. | 14.1 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 4.3 mio. | -5.3 mio. | 24.4 mio. | 22.2 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 4 mio. | -3.5 mio. | 12.4 mio. | 10.4 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 3.9 mio. | -2.8 mio. | 5.9 mio. | 4.5 mio. | - |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. Allarity Therapeutics A/S is registered in the Danish CVR register with the status Dissolved and ceased on 16 October 2025.
The CVR number of Allarity Therapeutics A/S is 28106351.
In 2024, Allarity Therapeutics A/S reported a gross profit of DKK -81,000.
Allarity Therapeutics A/S had 6 employees in 2021 according to the Danish CVR register.
Allarity Therapeutics A/S was founded on 9 September 2004.
Allarity Therapeutics A/S was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
As of October 16, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Allarity Therapeutics A/S.
As of October 16, 2025, Lars Lüthjohan has stepped down as liquidator of Allarity Therapeutics A/S.
On October 16, 2025, Allarity Therapeutics A/S exited liquidation.
Allarity Therapeutics A/S was dissolved on October 16, 2025.
Allarity Therapeutics A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -83,000.
Allarity Therapeutics A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -406,000.
Allarity Therapeutics A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -14,612,000.
Allarity Therapeutics A/S has published its annual report for 2021. Gross profit came to DKK 403,834,000, and the net result was DKK 565,758,000.
As of August 15, 2022, Søren Gade Jensen has left the board of directors of Allarity Therapeutics A/S.
As of August 15, 2022, Gail Maderis has left the board of directors of Allarity Therapeutics A/S.
As of August 15, 2022, Lars Lüthjohan is registered as liquidator of Allarity Therapeutics A/S.
As of August 15, 2022, Duncan Moore has stepped down as chairman of Allarity Therapeutics A/S.
As of August 15, 2022, James G. Cullem has stepped down as adm. dir. of Allarity Therapeutics A/S.
On August 15, 2022, Allarity Therapeutics A/S entered liquidation.
As of June 29, 2022, Stefano Roberto Carchedi has left the board of directors of Allarity Therapeutics A/S.
As of June 29, 2022, James G. Cullem is registered as adm. dir. of Allarity Therapeutics A/S.
As of June 29, 2022, Stefano Roberto Carchedi has stepped down as adm. dir. of Allarity Therapeutics A/S.
As of June 27, 2022, Jens Erik Knudsen has stepped down as director of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -47,706,000.
As of November 2, 2020, Jens Erik Knudsen is registered as director of Allarity Therapeutics A/S.
As of October 21, 2020, Henrik Kristian Moltke has stepped down as director of Allarity Therapeutics A/S.
As of October 7, 2020, Søren Gade Jensen has joined the board of directors of Allarity Therapeutics A/S.
As of October 7, 2020, Gail Maderis has joined the board of directors of Allarity Therapeutics A/S.
As of October 7, 2020, Steen Meier Knudsen has left the board of directors of Allarity Therapeutics A/S.
As of October 7, 2020, Gunnar Magnus Severus Modée Persson has left the board of directors of Allarity Therapeutics A/S.
As of October 7, 2020, Carani Sanjeevi has left the board of directors of Allarity Therapeutics A/S.
As of October 7, 2020, Frank Knudsen has stepped down as vice chairman of Allarity Therapeutics A/S.
On October 7, 2020, the company changed its name from ONCOLOGY VENTURE A/S to Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2019. Revenue came to DKK 801,000, and the net result was DKK -138,132,000.
As of October 15, 2019, Stefano Roberto Carchedi has joined the board of directors of Allarity Therapeutics A/S.
As of October 15, 2019, Peter Buhl has left the board of directors of Allarity Therapeutics A/S.
As of October 1, 2019, Henrik Kristian Moltke is registered as director of Allarity Therapeutics A/S.
As of September 15, 2019, Stefano Roberto Carchedi is registered as adm. dir. of Allarity Therapeutics A/S.
As of September 15, 2019, Peter Buhl has stepped down as adm. dir. of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2018. Revenue came to DKK 2,147,000, and the net result was DKK -15,544,000.
As of December 18, 2018, Carani Sanjeevi has joined the board of directors of Allarity Therapeutics A/S.
As of December 18, 2018, Niels Johansen has left the board of directors of Allarity Therapeutics A/S.
As of December 18, 2018, Frank Knudsen is registered as vice chairman of Allarity Therapeutics A/S.
As of December 18, 2018, Duncan Moore is registered as chairman of Allarity Therapeutics A/S.
As of December 17, 2018, Frank Knudsen has stepped down as chairman of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2017. Revenue came to DKK 5,145,000, and the net result was DKK -30,390,000.
On May 30, 2018, the company changed its name from MEDICAL PROGNOSIS INSTITUTE A/S to ONCOLOGY VENTURE A/S.
As of April 24, 2018, Jørgen Vilhelm Løvenørn Bardenfleth has left the board of directors of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2016. Revenue came to DKK 4,990,407, and the net result was DKK -8,729,384.
As of April 25, 2017, Jørgen Vilhelm Løvenørn Bardenfleth has joined the board of directors of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2015. Revenue came to DKK 5,837,783, and the net result was DKK -8,365,702.
Allarity Therapeutics A/S has published its annual report for 2014. Revenue came to DKK 4,315,459, and the net result was DKK -5,347,074.
As of April 21, 2015, Frank Knudsen is registered as chairman of Allarity Therapeutics A/S.
As of April 21, 2015, Jørgen Søberg Petersen has stepped down as chairman of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2013. Revenue came to DKK 4,049,607, and the net result was DKK -3,539,007.
As of April 24, 2014, Gunnar Magnus Severus Modée Persson has joined the board of directors of Allarity Therapeutics A/S.
Allarity Therapeutics A/S has published its annual report for 2012. Revenue came to DKK 3,943,474, and the net result was DKK -2,768,795.
As of June 27, 2012, Peter Buhl has joined the board of directors of Allarity Therapeutics A/S.
As of June 27, 2012, Jørgen Søberg Petersen is registered as chairman of Allarity Therapeutics A/S.
As of June 27, 2012, Frank Knudsen has stepped down as chairman of Allarity Therapeutics A/S.
As of March 1, 2012, Peter Buhl is registered as adm. dir. of Allarity Therapeutics A/S.
As of March 1, 2012, Jon Askaa has stepped down as adm. dir. of Allarity Therapeutics A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Allarity Therapeutics A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of Allarity Therapeutics A/S.
As of January 1, 2010, Jon Askaa is registered as adm. dir. of Allarity Therapeutics A/S.
As of January 1, 2010, Jesper Drejet has stepped down as adm. dir. of Allarity Therapeutics A/S.
On November 7, 2008, the company changed its name from MEDICAL PROGNOSIS INSTITUTE ApS to MEDICAL PROGNOSIS INSTITUTE A/S.
As of May 2, 2007, A/S PSE NR. 4820 has been appointed auditor of Allarity Therapeutics A/S.
As of May 2, 2007, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of Allarity Therapeutics A/S.
As of December 11, 2006, Jesper Drejet is registered as adm. dir. of Allarity Therapeutics A/S.
As of December 11, 2006, Steen Meier Knudsen has stepped down as director of Allarity Therapeutics A/S.
As of April 26, 2006, Frank Knudsen is registered as chairman of Allarity Therapeutics A/S.
As of April 26, 2006, Carsten Schou has stepped down as chairman of Allarity Therapeutics A/S.
As of March 30, 2005, Niels Johansen has joined the board of directors of Allarity Therapeutics A/S.
As of September 9, 2004, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Allarity Therapeutics A/S.
As of September 9, 2004, Steen Meier Knudsen has joined the board of directors of Allarity Therapeutics A/S.
As of September 9, 2004, Steen Meier Knudsen is registered as director of Allarity Therapeutics A/S.
As of September 9, 2004, Carsten Schou is registered as chairman of Allarity Therapeutics A/S.
Allarity Therapeutics A/S was founded on September 9, 2004.
Companies in the same industry and area
CVR 30514041
CVR 45284786
CVR 45284794
CVR 27408753
CVR 28512457
